CDw210b (IL-10Rβ), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-CDw210b (IL-10Rβ), Human antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CDw210b (IL-10Rβ), Human |
| Clone | REA848 |
| Host Species | Recombinant Human |
| Reactive Species | human |
| Isotype | IgG1 |
| Format | allophycocyanin (APC) conjugate |
| Size | 100 tests in 200 µL |
| Concentration | 1:50 |
| Applications | Flow cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CDw210b (IL-10Rβ) Antibody, anti-human, APC, REAfinity™. Clone REA848 recognizes the mouse CDw210b antigen, also known as interleukin-10 receptor beta (IL-10Rβ), a subunit of the IL-10 receptor. CDw210b is member of the type II cytokine receptor protein family and has an extracellular domain with two fibronectin type III domains. CDw210b is a component of the IL-22 receptor complex consisting of the IL-10Rβ and IL-22R and is expressed ubiquitously. | Additional information: Clone REA848 displays negligible binding to Fc receptors. |
| Immunogen | n/a |
| Other Names | Interleukin-10 receptor subunit beta, IL-10RB, CRF2-4, IL-10R2 |
| Gene, Accession # | Gene ID: 3588 |
| Catalog # | 130-112-707 |
| Price | $325 |
| Order / More Info | CDw210b (IL-10Rβ), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Xie, M. H. et al. (2013) Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J. Biol. Chem. 275 (40): 31335-31339. | Donnelly, R. P. et al. (2004) The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J. Leukoc. Biol. 76 (2): 314-321. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies